InvestorsHub Logo
Post# of 252190
Next 10
Followers 49
Posts 3516
Boards Moderated 0
Alias Born 08/24/2005

Re: DewDiligence post# 226421

Wednesday, 10/16/2019 10:32:23 AM

Wednesday, October 16, 2019 10:32:23 AM

Post# of 252190
ACHN > now trading @ 6.28 so the CVRs are basically free...

The transaction includes the potential for additional consideration in the form of non-tradeable contingent value rights (CVRs), which will be paid to Achillion shareholders if certain clinical and regulatory milestones are achieved within specified periods. These include $1.00 per share for the U.S. FDA approval of danicopan and $1.00 per share for ACH-5228 Phase 3 initiation.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.